Spark Investment Management LLC - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 35 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$32,0000.0%16,1000.0%0.01%0.0%
Q2 2014$32,000
-5.9%
16,100
+45.0%
0.01%0.0%
Q1 2014$34,000
-8.1%
11,1000.0%0.01%
-16.7%
Q4 2013$37,00011,1000.01%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,255,691$7,173,0005.84%
NEA Management Company, LLC 2,086,755$6,636,0000.26%
TOURADJI CAPITAL MANAGEMENT, LP 10,000$32,0000.10%
Loeb Offshore Management LP 101,000$321,0000.10%
BVF INC/IL 150,000$477,0000.08%
ABNER HERRMAN & BROCK LLC 20,000$64,0000.04%
SABBY MANAGEMENT, LLC 173,500$552,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 67,000$213,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 52,000$165,0000.00%
PANAGORA ASSET MANAGEMENT INC 96,858$307,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders